H
Hwail Pharm Co Ltd
KOSDAQ:061250
Hwail Pharm Co Ltd
KOSDAQ:061250
Price:
943
KRW
-2.18%
Market Cap:
₩79.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
KR |
|
Madhav Infra Projects Ltd
BSE:539894
|
IN |
|
C
|
Churchill Resources Inc
OTC:CRICF
|
CA |
|
V
|
Vista Gold Corp
TSX:VGZ
|
US |
|
P
|
Proficient Auto Logistics Inc
NASDAQ:PAL
|
US |
|
Star Combo Pharma Ltd
ASX:S66
|
AU |
|
Piccadily Agro Industries Ltd
BSE:530305
|
IN |
|
Bosideng International Holdings Ltd
HKEX:3998
|
HK |
|
DFI Inc
TWSE:2397
|
TW |
|
A
|
Alma Media Oyj
LSE:0DJN
|
FI |
|
N
|
NuVasive Inc
F:NK8
|
US |
|
H
|
HD Renewable Energy Co Ltd
TWSE:6873
|
TW |
|
Auckland International Airport Ltd
NZX:AIA
|
NZ |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XETRA:AIL
|
FR |
|
T
|
Taeyang Corp
KOSDAQ:053620
|
KR |
|
Red Rock Resorts Inc
NASDAQ:RRR
|
US |
|
Boralex Inc
TSX:BLX
|
CA |
|
G
|
Guizhou Qianyuan Power Co Ltd
SZSE:002039
|
CN |
|
Triad Group PLC
LSE:TRD
|
UK |
|
E
|
ES Australia Israel Holdings Ltd
TASE:AUIS
|
IL |
|
Prevas AB
STO:PREV B
|
SE |
|
GUD Holdings Ltd
ASX:GUD
|
AU |
|
Cerestar Indonesia Tbk PT
IDX:TRGU
|
ID |
Multiples-Based Value
The Multiples-Based Value for Hwail Pharm Co Ltd (061250) under the Base Case is hidden KRW. Compared with the current market price of 943 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hwail Pharm Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Hwail Pharm Co Ltd Competitors
Hwail Pharm Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
79.4B KRW | 0.8 | -340.7 | -3.1 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
